Cheng Lin, Yu Honghua, Yan Naihong, Lai Kunbei, Xiang Mengqing
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityGuangzhou, China; Department of Ophthalmology, General Hospital of Guangzhou Military Command of PLAGuangzhou, China.
Front Cell Neurosci. 2017 Feb 27;11:20. doi: 10.3389/fncel.2017.00020. eCollection 2017.
Hypoxia-inducible factor (HIF) is a transcription factor that facilitates cellular adaptation to hypoxia and ischemia. Long-standing evidence suggests that one isotype of HIF, HIF-1α, is involved in the pathogenesis of various solid tumors and cardiac diseases. However, the role of HIF-1α in retina remains poorly understood. HIF-1α has been recognized as neuroprotective in cerebral ischemia in the past two decades. Additionally, an increasing number of studies has shown that HIF-1α and its target genes contribute to retinal neuroprotection. This review will focus on recent advances in the studies of HIF-1α and its target genes that contribute to retinal neuroprotection. A thorough understanding of the function of HIF-1α and its target genes may lead to identification of novel therapeutic targets for treating degenerative retinal diseases including glaucoma, age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions.
缺氧诱导因子(HIF)是一种转录因子,可促进细胞对缺氧和缺血的适应。长期以来的证据表明,HIF的一种同型异构体HIF-1α参与了各种实体瘤和心脏疾病的发病机制。然而,HIF-1α在视网膜中的作用仍知之甚少。在过去二十年中,HIF-1α在脑缺血中被认为具有神经保护作用。此外,越来越多的研究表明,HIF-1α及其靶基因有助于视网膜神经保护。本综述将聚焦于HIF-1α及其靶基因在视网膜神经保护研究中的最新进展。深入了解HIF-1α及其靶基因的功能可能有助于确定治疗包括青光眼、年龄相关性黄斑变性、糖尿病视网膜病变和视网膜静脉阻塞在内的退行性视网膜疾病的新治疗靶点。